BEVACIZUMAB
Clinical Indication
Treatment of angiodysplasia in the background of von Willebrand's disease second line to thalidomide use.
Date of classification
March 2022
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.